The Pharmaceuticals and Medical Devices Agency (PMDA) is pleased to announce the “PMDA-ATC Pharmacovigilance Webinar 2024” for officials from overseas regulatory authorities who are engaged in pharmacovigilance activities. This webinar will be held virtually from February 26 to 29, 2024.
This webinar is held as the workshop of Asia-Pacific Economic Cooperation, Regulatory Harmonization Steering Committee (APEC-RHSC) Center of Excellence, however, the webinar is open to non-APEC economies as well.
The webinar aims to provide chances for the participants to refer back to their work and to find any additional opportunity for enhancement of the regulatory system in participant’s economies for pharmacovigilance in the post-marketing phase. The webinar will be led not only by PMDA staff members from pharmacovigilance area but also the representatives from academia and the pharmaceutical industry in Japan, allowing participants to think and discuss from multiple perspectives on pharmacovigilance. A representative from U.S.FDA will have a special session about pharmacovigilance activities in the US. In this time, we renew whole contents of group works from the previous seminar. Participants will work about ADR case evaluation, identification of safety specification and development of risk management plan.
Regulators ONLY (Beginner to Intermediate level)
Number of participants: approx. 30
Close of registration: December 25, 2023
In order to attend the webinar, please be sure to submit both of the following applications.
To apply for the webinar, please make sure to complete all the necessary items on the application form, including the signature by the applicant's supervisor, before the closing date.
Click the link to apply: https://www12.webcas.net/form/pub/pmda-atc/pv2024
All sessions will be conducted using the Cisco Webex Meeting system.
Please confirm the attached system requirements.
There is no registration fee for this webinar. Any expenses incurred with participation in the webinar will not be covered by PMDA.
For more information, please contact:
Secretariat, PMDA Asia Training Center
Asia Training Center for Pharmaceuticals and Medical Devices Regulatory Affairs
Pharmaceuticals and Medical Devices Agency
Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
(Note: For the purpose of security, @ in the e-mail addresses are replaced with ●. Please replace ● with @ when you send an e-mail.)